The x-ray absorption fine structure (XAFS) zinc K-edge steps for intact stages 1,11 and V,VI Xenopus laevis oocytes demonstrate that the zinc concentration is about 3 and 1 mM, respectively. However, the x(k) function for the early stage oocytes differs markedly from that for the late one. Analysis of the XAFS data for stage 1,11 oocytes indicates that zinc is bound to 2.0 ± 0.5 sulfur atoms at an average (3, 4). The isolation and purification of vitellogenin obtained from the serum of female X. laevis frogs was performed as described (8, 13) . Yolk platelets and purified lipovitellin were obtained from stage VI eggs (13). The zinc contents of purified proteins, yolk platelets, and oocytes were determined by atomic absorption spectrometry (3, 13). All XAFS measurements were performed on Beamline
The Xenopus laevis oocyte develops over a period of up to 3 years (1, 2). The oocytes take up zinc throughout all six stages of maturation, increasing from 5 x 10-2 nmol at stage I to as high as 2 nmol per oocyte at stage VI (3). This process correlates closely with an increase in the volume of the oocyte (4) that effectively keeps the zinc concentration in the range of 1-3 mM throughout oogenesis. The increase in zinc content and volume of developing oocytes correlates closely with uptake of vitellogenin (5-7), a zinc protein (8) that is synthesized in the liver under the influence of estrogen, secreted into plasma, and then taken up by oocyte through receptormediated endocytosis (9, 10) . The vitellogenin cleavage products, lipovitellin 1 and 2 and phosvitin, remain associated with each other in a microcrystalline state within yolk platelets in mature stage VI oocytes (1, 11, 12) . X. laevis vitellogenin and its processed product, lipovitellin, are zinc proteins containing 1 g at of zinc per mol of protein of 220 kDa (8) and 141 kDa (13) , respectively. As a result of this process, 90% of the total zinc is found within yolk platelets, bound to a single molecule, lipovitellin in mature stage VI oocytes (5, 13). In marked
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contrast, stage II oocytes have very few yolk platelets and the zinc is distributed principally in cytosolic regions (5).
The high zinc content of frog oocytes and the ability of x-ray absorption fine structure (XAFS) to determine the structure of zinc complexes in both solid and liquid states now permits the direct examination of zinc in intact oocytes at different stages of their development. We have therefore used XAFS to determine the ligand type, number, and their average coordination distance in the predominant zinc complexes in both early and late stages of oogenesis and that of the purified frog serum protein, i.e., vitellogenin, its processed microcrystalline form in yolk platelets, and its isolated cleavage product, lipovitellin. Moreover, the particular distribution of the zinc within the oocyte at the end of oogenesis (stage VI) allows assignment of the zinc signal to a specific protein species.
MATERIALS AND METHODS
All preparative steps were carried out in zinc-free conditions to obviate spurious contamination. Frog ovaries were removed from both 3-and 7-cm frogs to obtain oocytes at both early and late stages of development, respectively. Stage I,II and V,VI oocytes were pooled based on their size and color (3, 4). The isolation and purification of vitellogenin obtained from the serum of female X. laevis frogs was performed as described (8, 13) . Yolk platelets and purified lipovitellin were obtained from stage VI eggs (13) . The zinc contents of purified proteins, yolk platelets, and oocytes were determined by atomic absorption spectrometry (3, 13). All XAFS measurements were performed on Beamline X9-B of the National Synchrotron Light Source at Brookhaven National Laboratory as described (14, 15) . Yolk (14, 15) . The zinc K-edge x-ray absorption spectra were reduced to XAFS X functions, Fourier-transformed, and fitted by least squares analysis as described (14, 15 (18) .
The Fourier transforms performed on the x(k) function for the oocytes between 0.8 and 12.5 A-1 in k space (Fig. 1B) tAverage absorber-scatterer bond lengths. tMean square deviation in absorber-scatterer bond length.
§Fitting criteria (14) . procedure by first separating it from serum proteins through precipitation with 35% saturated (NH4)2S04 followed by Mono Q chromatography (8, 13) . Lipovitellin is obtained from isolated washed yolk platelets. The proteins in these oocyte organelles are solubilized and the lipovitellin is separated from phosvitin by treatment with 66% saturated (NH4)2S04 followed by Sepharose 6B chromatography. Lipovitellin contains 1 g at of zinc per mol of 141-kDa protein (13) .
The XAFS x(k) function of purified frog serum vitellogenin closely resembles the corresponding one for its microcrystalline processed form that is present in yolk platelets and for purified lipovitellin (Fig. 2A) . The Fourier transforms of the x(k) functions characterizing vitellogenin and its processed product, lipovitellin, both within intact yolk platelets and as a pure protein, generate pseudo radial distributions of atoms about the zinc ion. The Fourier transforms performed on these spectra between 0.8 and 12.5 A-1 in k space are very similar (Fig. 2B) . All three show a major first shell peak centered at 1.50-1.55 A and a higher shell distribution in the region of 3-4 A. Least-square fitting analysis of the data for purified vitellogenin show the zinc is bound to 3.9 + 0.5 N/O ligands at an average interatomic distance of 1.99 + 0.01 A ( Fig. 3 . These spectra are closely similar to that of the tetrahedral zinc complex ion Zn(Ac)2(Im)2 (14) . These analyses indicate that two imidazoles contribute to this region of the transform. This signal is mainly due to the C-4 and N-3 nitrogens of His residues that are colinear with the N-1 zinc ligand and thus cause a backscattering enhancement by a focusing effect (19) .
The Fourier transform of the stage I,II oocytes (Fig. 1B) (20, 24 
